Literature DB >> 31813986

Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator.

Alice Huertas1,2,3, Ly Tu1,2, Marc Humbert1,2,3, Christophe Guignabert1,2.   

Abstract

This review seeks to provide an update of preclinical findings and available clinical data on the chronic persistent inflammation and its direct role on the pulmonary arterial hypertension (PAH) progression. We reviewed the different mechanisms by which the inflammatory and immune pathways contribute to the structural and functional changes occurring in the three vascular compartments: the tunica intima, tunica media, and tunica adventitia. We also discussed how these inflammatory mediator changes may serve as a biomarker of the PAH progression and summarize unanswered questions and opportunities for future studies in this area. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Adventitial fibroblasts; Endothelial cells; Innate and adaptive immunity; Pulmonary hypertension; Pulmonary vascular remodelling; Smooth muscle cells

Year:  2020        PMID: 31813986     DOI: 10.1093/cvr/cvz308

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

1.  Celastrol attenuates the remodeling of pulmonary vascular and right ventricular in monocrotaline-induced pulmonary arterial hypertension in rats.

Authors:  Huayang Li; Quan Liu; Yuan Yue; Shunjun Wang; Suiqing Huang; Lin Huang; Li Luo; Yitao Zhang; Zhongkai Wu
Journal:  Cardiovasc Diagn Ther       Date:  2022-02

2.  Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency.

Authors:  Paul J Maglione; Jessica D Gereige; Theodore K Lee
Journal:  Ann Allergy Asthma Immunol       Date:  2021-10       Impact factor: 6.347

3.  Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.

Authors:  Christoph Tabeling; Carla R González Calera; Jasmin Lienau; Jakob Höppner; Thomas Tschernig; Olivia Kershaw; Birgitt Gutbier; Jan Naujoks; Julia Herbert; Bastian Opitz; Achim D Gruber; Berthold Hocher; Norbert Suttorp; Harald Heidecke; Gerd-R Burmester; Gabriela Riemekasten; Elise Siegert; Wolfgang M Kuebler; Martin Witzenrath
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 4.  Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension.

Authors:  Nicholas E King; Evan Brittain
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

5.  Single-Cell RNA Sequencing Reveals Novel Genes Regulated by Hypoxia in the Lung Vasculature.

Authors:  Shelby Thomas; Sathiyanarayanan Manivannan; Vidu Garg; Brenda Lilly
Journal:  J Vasc Res       Date:  2022-03-16       Impact factor: 2.045

6.  Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension.

Authors:  Matthew W Gorr; Krishna Sriram; Abinaya Muthusamy; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-15       Impact factor: 8.739

7.  ECM2 and GLT8D2 in human pulmonary artery hypertension: fruits from weighted gene co-expression network analysis.

Authors:  Zeyang Bai; Lianyan Xu; Yong Dai; Qingchen Yuan; Zihua Zhou
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

Review 8.  Vascular Homeostasis and Inflammation in Health and Disease-Lessons from Single Cell Technologies.

Authors:  Olga Bondareva; Bilal N Sheikh
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

9.  The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.

Authors:  Mehreen Batool; Eva M Berghausen; Mario Zierden; Marius Vantler; Ralph T Schermuly; Stephan Baldus; Stephan Rosenkranz; Henrik Ten Freyhaus
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

10.  Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.

Authors:  Judith Bernal-Ramírez; Christian Silva-Platas; Carlos Jerjes-Sánchez; Martín R Ramos-González; Eduardo Vázquez-Garza; Héctor Chapoy-Villanueva; Alicia Ramírez-Rivera; Ángel Zarain-Herzberg; Noemi García; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2021-06-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.